Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Moodys
Baxter
AstraZeneca
Boehringer Ingelheim

Last Updated: May 21, 2022

CLINICAL TRIALS PROFILE FOR NICLOSAMIDE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Niclosamide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00138359 ↗ Mass Treatment T Solium Community Study Terminated National Institute of Allergy and Infectious Diseases (NIAID) N/A 2004-12-01 Investigators from Cayetano Heredia University and Johns Hopkins University are doing this study. They want to see how people and pigs get infected with a parasite, called cysticercus (known as "pig triquina"). Cysticercus attacks the meat of pigs and the brains of people. In the intestine, the parasite is known as "solitaria". This study is to see how treatment in both people and pigs works to control the disease.
NCT01296958 ↗ Targeted Screening for Taenia Solium Tapeworms Completed National Institute of Neurological Disorders and Stroke (NINDS) N/A 2011-05-01 The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection.
NCT01296958 ↗ Targeted Screening for Taenia Solium Tapeworms Completed National University of San Marcos, Peru N/A 2011-05-01 The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Niclosamide

Condition Name

Condition Name for Niclosamide
Intervention Trials
Covid19 8
COVID-19 4
Healthy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Niclosamide
Intervention Trials
COVID-19 15
Carcinoma 3
Prostatic Neoplasms 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Niclosamide

Trials by Country

Trials by Country for Niclosamide
Location Trials
United States 16
India 6
Germany 4
Korea, Republic of 3
Peru 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Niclosamide
Location Trials
California 4
Texas 2
Florida 2
Alabama 2
Idaho 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Niclosamide

Clinical Trial Phase

Clinical Trial Phase for Niclosamide
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 2/Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Niclosamide
Clinical Trial Phase Trials
Recruiting 15
Completed 7
Not yet recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Niclosamide

Sponsor Name

Sponsor Name for Niclosamide
Sponsor Trials
Daewoong Pharmaceutical Co. LTD. 4
National Cancer Institute (NCI) 3
UNION therapeutics 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Niclosamide
Sponsor Trials
Other 38
Industry 20
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Merck
McKinsey
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.